amlodipine has been researched along with ramipril in 95 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (9.47) | 18.2507 |
| 2000's | 44 (46.32) | 29.6817 |
| 2010's | 37 (38.95) | 24.3611 |
| 2020's | 5 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Sun, H | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Ceravolo, R; Mattioli, PL; Perticone, F; Pugliese, F | 1 |
| Bowell, GR | 1 |
| Hintze, TH; Zhang, X | 1 |
| Bernstein, R; Hintze, TH; Nasjletti, A; Recchia, FA; Xu, X; Zhang, X | 1 |
| Doe, CP; Flynn, DM; Forfia, PR; Hintze, TH; Knight, DR; Smith, AH; Wolfgang, EA; Wolin, MS; Zhang, X | 1 |
| Hintze, TH; Kaley, G; Kichuk, MR; Michler, R; Mital, S; Nasjletti, A; Oz, M; Zhang, X | 1 |
| Addonizio, L; Bernstein, R; Hintze, TH; Kaley, G; Laycock, SK; Loke, KE; Mital, S; Oz, M; Wolin, MS | 1 |
| Carretero, OA; Curran, CM; Hintze, TH; Laycock, SK; Loke, KE; Messina, EJ; Shesely, EG | 1 |
| Hintze, TH; Nasjletti, A; Xu, X; Zhang, X | 1 |
| Addonizio, L; Gersony, WM; Hintze, TH; Loke, KE; Mital, S; Slater, JP | 1 |
| Bishop, JE; Gohlke, P; Kiernan, LA; McEwan, JR; Montgomery, HE | 1 |
| Forfia, PR; Hintze, TH; Liao, J; Loke, KE; Magneson, A; Mital, S | 1 |
| Hintze, TH; Loke, KE; Messina, EJ; Mital, S | 1 |
| Hintze, TH; Kaley, G; Loke, KE; Messina, EJ; Shesely, EG | 1 |
| Adler, S; Hintze, TH; Huang, H; Laumas, A; Loke, K; Xu, X | 1 |
| Agodoa, LY; Appel, L; Bakris, GL; Beck, G; Bourgoignie, J; Briggs, JP; Charleston, J; Cheek, D; Cleveland, W; Douglas, JG; Douglas, M; Dowie, D; Faulkner, M; Gabriel, A; Gassman, J; Greene, T; Hall, Y; Hebert, L; Hiremath, L; Jamerson, K; Johnson, CJ; Kopple, J; Kusek, J; Lash, J; Lea, J; Lewis, JB; Lipkowitz, M; Massry, S; Middleton, J; Miller, ER; Norris, K; O'Connor, D; Ojo, A; Phillips, RA; Pogue, V; Rahman, M; Randall, OS; Rostand, S; Schulman, G; Smith, W; Thornley-Brown, D; Tisher, CC; Toto, RD; Wright, JT; Xu, S | 1 |
| Dernellis, J | 1 |
| Vidt, DG | 1 |
| Adler, S; Gupta, S; Hintze, TH; Huang, H; Trochu, JN; Xu, X | 1 |
| McConaghy, JR | 1 |
| Flack, JM | 1 |
| Studney, D | 1 |
| Agodoa, LY; Appel, LJ; Bakris, G; Charleston, J; Cheek, D; Douglas-Baltimore, JG; Gassman, J; Glassock, R; Greene, T; Hebert, L; Jamerson, K; Lewis, J; Middleton, JP; Phillips, RA; Rostand, SG; Toto, RD; Wright, JT | 1 |
| Bellini, MA; Boschi, L; Forconi, S; Guerrini, M; Pallassini, A; Postorino, G; Richichi, MG; Trabalzini, L; Turchetti, V | 1 |
| Fukuda, M; Kimura, G; Usami, T; Yoshida, A | 1 |
| Rahman, M | 1 |
| Agodoa, L; Douglas, JG | 1 |
| Ferdinand, KC | 1 |
| Liebisch, B | 1 |
| de Champlain, J; Lacourcière, Y; Lamarre-Cliche, M; Larochelle, P; Poirier, L | 1 |
| de Champlain, J; Karas, M; Lacourcière, Y; Lamarre-Cliche, M; Larochelle, P; Poirier, L | 1 |
| de Champlain, J; Dubé, B; Florescu, M; Karas, M; Lacourcière, Y; Lamarre-Cliche, M; Larochelle, P; LeBlanc, AR; Nadeau, R; Poirier, L | 1 |
| Agodoa, LY; Cheek, D; Contreras, G; Dowie, D; Greene, T; Junco, G; Lash, J; Lipkowitz, M; Miller, ER; Ojo, A; Sika, M; Toto, RD; Wilkening, B | 1 |
| Bhushan, R; Gupta, D; Singh, SK | 1 |
| Bertoluci, MC; Oliveira, FR; Schmid, H; Schmidt, A; Thomazelli, FC; Uebel, D | 1 |
| Agodoa, LY; Appel, LJ; Cheek, D; Contreras, G; Gassman, J; Lash, JP; Miller, ER; Randall, OS; Thornley-Brown, D; Wang, X; Wright, JT | 1 |
| Gadegbeku, CA; Greene, T; Hall, Y; Jones, K; Kusek, JW; Lash, JP; Sika, M; Unruh, M; Wang, X | 1 |
| Toto, RD | 1 |
| Coelho, EB; da Silva, CA; Fazan, R; Nobre, F; Salgado, HC | 1 |
| Cao, G; DeRosa, G; Domecq, P; Rivas, C; Toblli, JE | 1 |
| Bizot, MN; Denouel, J; Dieterich, HA; Dole, WP; Kemp, C; Vaidyanathan, S; Valencia, J; Yeh, CM; Zhao, C | 1 |
| Acikel, C; Caglar, K; Celik, T; Eyileten, T; Oguz, Y; Sonmez, A; Vural, A; Yavuz, I; Yenicesu, M; Yilmaz, MI | 1 |
| Campestrini, J; Dole, K; Dole, WP; He, YL; Howard, D; Ligueros-Saylan, M; Marion, A; Pommier, F; Sabo, R; Sunkara, G; Wang, Y; Zhao, C | 1 |
| Corradi, L; Derosa, G; Ferrari, I; Fogari, R; Lazzari, P; Mugellini, A; Preti, P; Santoro, T; Zoppi, A | 1 |
| Hedner, T; Kjeldsen, SE; Narkiewicz, K; Oparil, S | 1 |
| Amodeo, C; Filho, BL; Gomes, MA; Kohlmann, O; Mion, D; Miranda, RD; Rocha, JC; Saraiva, JF | 1 |
| Han, SH; Kim, SJ; Koh, KK; Koh, Y; Lee, Y; Quon, MJ; Shin, EK | 1 |
| Borbas, E; Handrock, R; Klebs, S; Schaetzl, R; Trenkwalder, P | 1 |
| Albert, DH; Banfor, PN; Cox, BF; Davidsen, SK; Franklin, PH; Fryer, RM; Gintant, GA; Larson, KJ; Noonan, WT; Segreti, JA; Tapang, P; Widomski, DL | 1 |
| Barabashkina, AV; Novikova, IM; Runikhina, NK; Tkacheva, ON | 1 |
| Accardo, S; Americo, L; Castello, A; Cicero, S; Sarullo, FM; Schicchi, R; Schirò, M | 1 |
| Inamadugu, JK; Karra, VK; Mullangi, R; Pilli, NR; Rao, JV; Vaidya, JR | 1 |
| Akinci, D; Altun, B; Kahraman, S; Ozer, N; Turgan, C; Yilmaz, R | 1 |
| Bilo, G; Mancia, G; Parati, G; Schumacher, H | 1 |
| Bakan, E; Borekci, B; Kumbasar, S; Kumtepe, Y; Salman, S; Suleyman, H; Yilmaz, M | 1 |
| Appel, LJ; Astor, BC; Davis, EM; Greene, T; Lipkowitz, MS; Pogue, VA; Rahman, M; Toto, R; Wang, X; Wright, JT | 1 |
| Chobanian, AV | 1 |
| Derosa, G; Fogari, R; Maffioli, P; Mugellini, A; Preti, P; Zoppi, A | 1 |
| Bektaş, O; Karahan, SC; Kaynar, K; Menteşe, A; Ozkan, G; Sönmez, M; Ulusoy, S | 1 |
| Doros, A; Fekete, A; Langer, RM; Rudolf, A; Wagner, L | 1 |
| Dussouil, AS; Gaudy-Marqueste, C; Grob, JJ; Mallet, S; Monestier, S; Richard, MA; Tasei, AM | 1 |
| Simonyi, G | 2 |
| Chazova, IE; Martyniuk, TV | 1 |
| Agaliotis, GD; Andreadis, EA; Angelopoulos, ET; Kolyvas, GN; Mousoulis, CG; Mousoulis, GP | 1 |
| Azizi, M; Bobrie, G; Chatellier, G; Frank, M; Ménard, J; Perdrix, L; Plouin, PF | 1 |
| Cetinkaya, H; Eyileten, T; Gok, M; Karaman, M; Kurt, YG; Mallamaci, F; Oguz, Y; Saglam, M; Sonmez, A; Unal, HU; Vural, A; Yilmaz, MI; Zoccali, C | 1 |
| Ferenci, T; Simonyi, G | 3 |
| Almgren-Rachtan, A; Chudek, J; Olszanecka-Glinianowicz, M; Smertka, M | 1 |
| Angeloni, E; Lombardo, P; Pirelli, M; Refice, S; Vitaterna, A | 1 |
| Avtandilov, AG; Zapesochnaia, IL | 1 |
| Anthony, EG; Bhatnagar, V; Lipkowitz, MS; Richard, E | 1 |
| Alföldi, S; Farsang, C; Ferenci, T; Simonyi, G | 1 |
| Buda, S; Degli Esposti, E; Degli Esposti, L; Sangiorgi, D; Scaglione, F | 1 |
| Gridina, SA; Povetkin, SV | 1 |
| Bramlage, P; Schmidt, S; Sims, H | 1 |
| Armario, P; Banegas, JR; de la Cruz, JJ; de la Sierra, A; Gorostidi, M; Oliveras, A; Ruilope, LM; Segura, J; Vinyoles, E | 1 |
| Augustin, M; Gründer, G; Haen, E; Paulzen, M; Schoretsanitis, G | 1 |
| Appel, LJ; Juraschek, SP; Lipsitz, LA; Miller, ER; Mukamal, KJ | 1 |
| Bachmann, HS; Besser, M; Severing, AL; Stuermer, EK; Terberger, N | 1 |
| Taddei, S | 1 |
| Achino, C; Fellahi, JL; Jacquemet, PL; Jacquet-Lagrèze, M; Schweizer, R | 1 |
| Attala, K; Elsonbaty, A | 1 |
| Gundlach, K; Hermann, R; Seiler, D | 1 |
| Prokosa, MI | 1 |
| Kassie, GM; Kerr, M; Moffat, A; Pratt, N; Roughead, EE | 1 |
7 review(s) available for amlodipine and ramipril
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Angiotensin blockade in type 2 diabetes: what the new evidence tells us about renal and cardiac complications.
Topics: Albuminuria; Amlodipine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biphenyl Compounds; Calcium Channel Blockers; Captopril; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Complications; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Nephropathies; Humans; Irbesartan; Kidney Diseases; Losartan; Prognosis; Ramipril; Tetrazoles | 2002 |
Recommendations for the management of special populations: racial and ethnic populations.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Black or African American; Calcium Channel Blockers; Chlorthalidone; Diuretics; Drug Therapy, Combination; Female; Humans; Hypertension; Lisinopril; Male; Ramipril; Randomized Controlled Trials as Topic | 2003 |
Lessons from the African-American Study of Kidney Disease and Hypertension: an update.
Topics: Adrenergic beta-Antagonists; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Black People; Blood Pressure; Calcium Channel Blockers; Double-Blind Method; Drug Therapy, Combination; Glomerular Filtration Rate; Humans; Hypertension; Kidney Failure, Chronic; Metoprolol; Nephrosclerosis; Ramipril; Randomized Controlled Trials as Topic; Treatment Outcome | 2006 |
Evaluating 24-h antihypertensive efficacy by the smoothness index: a meta-analysis of an ambulatory blood pressure monitoring database.
Topics: Amlodipine; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Databases, Factual; Female; Humans; Losartan; Male; Ramipril; Randomized Controlled Trials as Topic; Telmisartan; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2010 |
[Advantages of ramipril/amlodipin fixed combination therapy. When should we use it?].
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Drug Administration Schedule; Drug Combinations; Humans; Hungary; Hypertension; Medication Adherence; Ramipril; Randomized Controlled Trials as Topic; Treatment Outcome | 2013 |
ACE-inhibitor/calcium antagonist combination: is this the first-choice therapy in arterial hypertension?
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Drug Combinations; Humans; Hypertension; Practice Guidelines as Topic; Ramipril; Treatment Outcome | 2019 |
31 trial(s) available for amlodipine and ramipril
| Article | Year |
|---|---|
Amlodipine versus ramipril in the treatment of mild to moderate hypertension: evaluation by 24-hour ambulatory blood pressure monitoring.
Topics: Adult; Amlodipine; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Double-Blind Method; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Ramipril; Single-Blind Method | 1994 |
Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Black or African American; Calcium Channel Blockers; Double-Blind Method; Female; Glomerular Filtration Rate; Humans; Hypertension; Kidney Failure, Chronic; Male; Metoprolol; Middle Aged; Nephrosclerosis; Proportional Hazards Models; Proteinuria; Ramipril | 2001 |
Clinical trials report. The effect of Ramipril versus Amlodipine on renal outcomes in hypertension nephrosclerosis.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Creatinine; Humans; Hypertension; Kidney; Kidney Failure, Chronic; Nephrosclerosis; Ramipril | 2001 |
What is the best treatment for slowing the progression to end-stage renal disease (ESRD) in African Americans with hypertensive nephropathy?
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Black People; Double-Blind Method; Female; Glomerular Filtration Rate; Humans; Hypertension, Renal; Kidney Failure, Chronic; Male; Metoprolol; Middle Aged; Ramipril | 2001 |
Effect of ramipril versus amlodipine on renal outcomes in hypertensive nephrosclerosis.
Topics: Adolescent; Adult; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Black People; Calcium Channel Blockers; Female; Humans; Hypertension; Male; Middle Aged; Nephrosclerosis; Prospective Studies; Ramipril; Treatment Outcome | 2002 |
Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Black or African American; Blood Pressure; Calcium Channel Blockers; Disease Progression; Female; Glomerular Filtration Rate; Humans; Hypertension; Kidney Failure, Chronic; Male; Metoprolol; Middle Aged; Proportional Hazards Models; Proteinuria; Ramipril | 2002 |
ACE inhibition is effective and renoprotective in hypertensive nephrosclerosis: the African American Study of Kidney Disease and Hypertension (AASK) trial.
Topics: Adrenergic beta-Antagonists; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Black or African American; Calcium Channel Blockers; Glomerular Filtration Rate; Humans; Hypertension, Renal; Metoprolol; Nephrosclerosis; Ramipril; Renal Insufficiency | 2003 |
A comparison of the efficacy and duration of action of telmisartan, amlodipine and ramipril in patients with confirmed ambulatory hypertension.
Topics: Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Female; Humans; Hypertension; Male; Middle Aged; Ramipril; Renin; Telmisartan; Therapeutic Equivalency | 2004 |
Effects of circadian rhythms, posture, and medication on renin-aldosterone interrelations in essential hypertensives.
Topics: Adult; Aged; Aldosterone; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Calcium Channel Blockers; Circadian Rhythm; Female; Humans; Hyperaldosteronism; Hypertension; Male; Middle Aged; Posture; Prospective Studies; Ramipril; Reference Values; Renin; Renin-Angiotensin System; Telmisartan; Treatment Outcome | 2005 |
Effect of the renin-angiotensin system or calcium channel blockade on the circadian variation of heart rate variability, blood pressure and circulating catecholamines in hypertensive patients.
Topics: Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Circadian Rhythm; Epinephrine; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Norepinephrine; Ramipril; Renin-Angiotensin System; Telmisartan; Treatment Outcome | 2005 |
Blood pressure control, drug therapy, and kidney disease.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Black or African American; Blood Pressure; Calcium Channel Blockers; Double-Blind Method; Glomerular Filtration Rate; Humans; Hypertension; Kidney; Kidney Failure, Chronic; Metoprolol; Middle Aged; Proteinuria; Ramipril; Treatment Outcome | 2005 |
Urinary TGF-beta1 reduction related to a decrease of systolic blood pressure in patients with type 2 diabetes and clinical diabetic nephropathy.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Glucose; Blood Pressure; Captopril; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Therapy, Combination; Enalapril; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Potassium; Propranolol; Ramipril; Transforming Growth Factor beta1 | 2006 |
Quality of life in the African American Study of Kidney Disease and Hypertension: effects of blood pressure management.
Topics: Adolescent; Adult; Aged; Amlodipine; Antihypertensive Agents; Black or African American; Blood Pressure; Female; Humans; Hypertension; Kidney Diseases; Male; Metoprolol; Middle Aged; Nephrosclerosis; Outcome Assessment, Health Care; Quality of Life; Ramipril | 2006 |
Effect of antihypertensive agents on plasma adiponectin levels in hypertensive patients with metabolic syndrome.
Topics: Adiponectin; Adrenergic beta-Antagonists; Adult; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Body Mass Index; Calcium Channel Blockers; Doxazosin; Female; Humans; Hypertension; Insulin Resistance; Lipids; Male; Metabolic Syndrome; Metoprolol; Middle Aged; Predictive Value of Tests; Prospective Studies; Ramipril; Tetrazoles; Time Factors; Treatment Outcome; Valine; Valsartan | 2007 |
Vildagliptin, a novel dipeptidyl peptidase IV inhibitor, has no pharmacokinetic interactions with the antihypertensive agents amlodipine, valsartan, and ramipril in healthy subjects.
Topics: Adamantane; Administration, Oral; Adult; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Area Under Curve; Cross-Over Studies; Dipeptidyl-Peptidase IV Inhibitors; Drug Interactions; Female; Half-Life; Headache; Humans; Male; Middle Aged; Nausea; Nitriles; Pyrrolidines; Ramipril; Tablets; Tetrazoles; Valine; Valsartan; Vildagliptin | 2008 |
Effect of valsartan and ramipril on atrial fibrillation recurrence and P-wave dispersion in hypertensive patients with recurrent symptomatic lone atrial fibrillation.
Topics: Aged; Amlodipine; Antihypertensive Agents; Atrial Fibrillation; Double-Blind Method; Electrocardiography; Female; Humans; Male; Peptide Fragments; Procollagen; Ramipril; Recurrence; Tetrazoles; Valine; Valsartan | 2008 |
An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
Topics: Adult; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Brazil; Calcium Channel Blockers; Double-Blind Method; Drug Therapy, Combination; Edema; Female; Humans; Hypertension; Male; Middle Aged; Prospective Studies; Ramipril | 2008 |
Distinct vascular and metabolic effects of different classes of anti-hypertensive drugs.
Topics: Adipokines; Adiponectin; Adult; Aged; Amlodipine; Antihypertensive Agents; Atenolol; Benzimidazoles; Biphenyl Compounds; Cholesterol, HDL; Comorbidity; Endothelium, Vascular; Female; Humans; Hypertension; Male; Middle Aged; Ramipril; Single-Blind Method; Tetrazoles; Triglycerides | 2010 |
Combination of amlodipine 10 mg and valsartan 160 mg lowers blood pressure in patients with hypertension not controlled by an ACE inhibitor/CCB combination.
Topics: Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Drug Resistance; Drug Therapy, Combination; Felodipine; Female; Humans; Hypertension; Male; Middle Aged; Ramipril; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2008 |
[The study of effects of ramipril and amlodipine combination in patients with arterial hypertension and type 2 diabetes mellitus].
Topics: Adult; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Hypertension; Male; Middle Aged; Ramipril; Time Factors; Treatment Outcome | 2009 |
Impact of amlodipine or ramipril treatment on left ventricular mass and carotid intima-media thickness in nondiabetic hemodialysis patients.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Atherosclerosis; Carotid Arteries; Female; Heart Ventricles; Humans; Hypertension; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Male; Middle Aged; Ramipril; Renal Dialysis; Stroke Volume; Tunica Intima; Tunica Media; Ultrasonography | 2010 |
Limitations of analyses based on achieved blood pressure: lessons from the African American study of kidney disease and hypertension trial.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Black or African American; Blood Pressure; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Hypertension; Kidney Diseases; Male; Metoprolol; Middle Aged; Proportional Hazards Models; Ramipril; Time Factors; Treatment Outcome | 2011 |
Effects of valsartan or ramipril addition to amlodipine/hydrochlorothiazide combination on left ventricular mass in diabetic hypertensive patients with left ventricular hypertrophy.
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Ramipril; Tetrazoles; Valine; Valsartan | 2012 |
[Possibilities of rational combination antihypertensive therapy: results of HEMERA international clinical trial].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Blood Pressure; Diuretics; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Prospective Studies; Ramipril; Treatment Outcome; Young Adult | 2013 |
The effect of aliskiren versus ramipril-based treatment on the Ambulatory Arterial Stiffness Index in hypertensive patients.
Topics: Adult; Aged; Amides; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Drug Therapy, Combination; Fumarates; Greece; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Predictive Value of Tests; Ramipril; Renin-Angiotensin System; Sodium Chloride Symporter Inhibitors; Time Factors; Treatment Outcome; Vascular Stiffness; Vasodilator Agents | 2014 |
Greater efficacy of aldosterone blockade and diuretic reinforcement vs. dual renin-angiotensin blockade for left ventricular mass regression in patients with resistant hypertension.
Topics: Adolescent; Adult; Aged; Aldosterone; Amiloride; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Biphenyl Compounds; Bisoprolol; Blood Pressure; Blood Pressure Determination; Diuretics; Drug Therapy, Combination; Female; Furosemide; Humans; Hypertension; Hypertrophy, Left Ventricular; Irbesartan; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Ramipril; Renin; Renin-Angiotensin System; Spironolactone; Tetrazoles; Young Adult | 2014 |
Ramipril lowers plasma FGF-23 in patients with diabetic nephropathy.
Topics: Adult; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Endothelium, Vascular; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Follow-Up Studies; Humans; Ischemia; Kidney Failure, Chronic; Male; Middle Aged; Phosphates; Proteinuria; Ramipril; Regression Analysis; Retrospective Studies | 2014 |
[The influence of combined therapy with calcium antagonist and angiotensin-converting enzyme inhibitor on the circadian profile of arterial pressure in patients with arterial hypertension in the Far North].
Topics: Adult; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium Channel Blockers; Circadian Clocks; Cold Climate; Drug Monitoring; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Ramipril; Severity of Illness Index; Siberia; Treatment Outcome | 2014 |
Association of the ADRB2 (rs2053044) polymorphism and angiotensin-converting enzyme-inhibitor blood pressure response in the African American Study of Kidney Disease and Hypertension.
Topics: 5' Untranslated Regions; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Black or African American; Blood Pressure; Female; Humans; Hypertension; Male; Metoprolol; Ramipril; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2 | 2015 |
Benefits of Fixed Dose Combination of Ramipril/Amlodipine in Hypertensive Diabetic Patients: A Subgroup Analysis of RAMONA Trial.
Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Male; Middle Aged; Ramipril | 2016 |
Hypertension Treatment Effects on Orthostatic Hypotension and Its Relationship With Cardiovascular Disease.
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Determination; Cardiovascular Diseases; Drug Monitoring; Female; Humans; Hypertension; Hypotension, Orthostatic; Male; Metoprolol; Middle Aged; Outcome Assessment, Health Care; Ramipril; United States | 2018 |
57 other study(ies) available for amlodipine and ramipril
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Capture hydrolysis signals in the microsomal stability assay: molecular mechanisms of the alkyl ester drug and prodrug metabolism.
Topics: Carboxylic Acids; Cytochrome P-450 Enzyme System; Esters; Humans; Hydrolysis; Microsomes; Models, Molecular; Molecular Structure; Prodrugs; Quantum Theory; Signal Transduction | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Hypertension medication and periodontosis.
Topics: Adult; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Anticonvulsants; Antihypertensive Agents; Calcium Channel Blockers; Gingival Hyperplasia; Humans; Male; Periodontal Diseases; Phenytoin; Ramipril | 1997 |
Amlodipine releases nitric oxide from canine coronary microvessels: an unexpected mechanism of action of a calcium channel-blocking agent.
Topics: Amlodipine; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Animals; Calcium Channel Blockers; Coronary Vessels; Diltiazem; Dogs; Dose-Response Relationship, Drug; Enalaprilat; In Vitro Techniques; Male; Nitric Oxide; Ramipril; Regression Analysis | 1998 |
Kinin-mediated coronary nitric oxide production contributes to the therapeutic action of angiotensin-converting enzyme and neutral endopeptidase inhibitors and amlodipine in the treatment in heart failure.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin Receptor Antagonists; Coronary Vessels; Cysteine Proteinase Inhibitors; Dogs; Enalaprilat; Glycopeptides; Heart Failure; Kininogens; Kinins; Nitric Oxide; Protease Inhibitors; Ramipril; Receptor, Bradykinin B2; Thiorphan; Vasodilator Agents | 1999 |
NO modulates myocardial O2 consumption in the nonhuman primate: an additional mechanism of action of amlodipine.
Topics: Amlodipine; Animals; Bradykinin; Calcium Channel Blockers; Enzyme Inhibitors; Female; Hemodynamics; In Vitro Techniques; Macaca fascicularis; Male; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Oxygen Consumption; Penicillamine; Ramipril; S-Nitroso-N-Acetylpenicillamine | 1999 |
Amlodipine promotes kinin-mediated nitric oxide production in coronary microvessels of failing human hearts.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Bradykinin; Bradykinin Receptor Antagonists; Calcium Channel Blockers; Cardiac Output, Low; Coronary Vessels; Dose-Response Relationship, Drug; Glycopeptides; Humans; Metalloendopeptidases; Microcirculation; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitrites; Quinine; Ramipril; Serine Proteinase Inhibitors; Thiorphan | 1999 |
Nitric oxide modulates mitochondrial respiration in failing human heart.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Bradykinin; Calcium Channel Blockers; Humans; In Vitro Techniques; Mitochondria, Muscle; Myocardium; Neprilysin; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroglycerin; Oxygen Consumption; Ramipril; Thiorphan; Vasodilator Agents | 1999 |
Role of nitric oxide in the control of cardiac oxygen consumption in B(2)-kinin receptor knockout mice.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Calcium Channel Blockers; Drug Interactions; Enzyme Inhibitors; Female; Heart; Mice; Mice, Knockout; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxygen Consumption; Ramipril; Receptors, Bradykinin; Substance P | 1999 |
Amlodipine enhances NO production induced by an ACE inhibitor through a kinin-mediated mechanism in canine coronary microvessels.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Calcium Channel Blockers; Coronary Vessels; Coumarins; Dogs; Dose-Response Relationship, Drug; Drug Synergism; In Vitro Techniques; Kallikreins; Microcirculation; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitrites; Ramipril | 2000 |
Synergy of amlodipine and angiotensin-converting enzyme inhibitors in regulating myocardial oxygen consumption in normal canine and failing human hearts.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Bradykinin Receptor Antagonists; Calcium Channel Blockers; Child; Coumarins; Dogs; Drug Synergism; Drug Therapy, Combination; Female; Heart Failure; Humans; Isocoumarins; Male; Middle Aged; Myocardial Contraction; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Oxygen Consumption; Penicillamine; Ramipril; Serine Proteinase Inhibitors | 1999 |
Raised blood pressure, not renin-angiotensin systems, causes cardiac fibrosis in TGR m(Ren2)27 rats.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Genetically Modified; Antihypertensive Agents; Collagen; Fibrosis; Hypertension; Hypertrophy, Left Ventricular; Male; Mice; Myocardium; Peptidyl-Dipeptidase A; Ramipril; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Time Factors | 2000 |
Simvastatin acts synergistically with ACE inhibitors or amlodipine to decrease oxygen consumption in rat hearts.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Calcium Channel Blockers; Drug Synergism; Heart; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Male; Myocardium; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Oxygen Consumption; Penicillamine; Ramipril; Rats; Rats, Wistar; S-Nitroso-N-Acetylpenicillamine; Simvastatin; Up-Regulation | 2000 |
Impaired nitric oxide modulation of myocardial oxygen consumption in genetically cardiomyopathic hamsters.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Bradykinin; Cardiomyopathies; Cricetinae; Dose-Response Relationship, Drug; Echocardiography; Enzyme Inhibitors; Kinins; Male; Mesocricetus; Muscles; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Organ Size; Oxygen; Oxygen Consumption; Penicillamine; Ramipril; Vasodilator Agents | 2000 |
Potential role of eNOS in the therapeutic control of myocardial oxygen consumption by ACE inhibitors and amlodipine.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Animals; Calcium Channel Blockers; Carbachol; Cardiotonic Agents; Culture Techniques; Diltiazem; Dose-Response Relationship, Drug; Female; Male; Mice; Mice, Inbred C57BL; Myocardium; Nitric Oxide Donors; Nitric Oxide Synthase; Oxygen Consumption; Ramipril; S-Nitroso-N-Acetylpenicillamine; Substance P; Vasodilator Agents | 2001 |
Modulation of renal oxygen consumption by nitric oxide is impaired after development of congestive heart failure in dogs.
Topics: Amlodipine; Animals; Bradykinin; Cardiac Pacing, Artificial; Dogs; Female; Heart Failure; Kidney; Nitric Oxide; Nitric Oxide Donors; Oxygen Consumption; Ramipril | 2001 |
Hypertensive African Americans with kidney disease should seek advice from doctor about blood pressure medication.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Black or African American; Calcium Channel Blockers; Humans; Hypertension; Kidney Diseases; Ramipril | 2001 |
Right atrial function in hypertensive patients: effects of antihypertensive therapy.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Atrial Function, Right; Echocardiography, Doppler; Female; Humans; Hypertension; Male; Middle Aged; Ramipril | 2001 |
Simvastatin reverses impaired regulation of renal oxygen consumption in congestive heart failure.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Dogs; Endothelium, Vascular; Heart Failure; Hemodynamics; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney; Kidney Cortex; Kidney Medulla; Male; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Oxygen Consumption; Penicillamine; Ramipril; Simvastatin; Ventricular Function, Left | 2001 |
Haemorheological and endothelial-dependent alterations in heart failure after ACE inhibitor, calcium antagonist and beta blocker.
Topics: Adrenergic beta-Antagonists; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Arginine; Blood Viscosity; Calcium; Carbazoles; Carvedilol; Citrulline; Erythrocytes; Female; Fibrinogen; Heart Failure; Humans; Male; Middle Aged; Nitric Oxide Synthase; Propanolamines; Ramipril; Time Factors; Treatment Outcome; Vascular Cell Adhesion Molecule-1; Vasodilator Agents | 2002 |
Antihypertensive drugs and renal protection.
Topics: Adrenergic beta-Antagonists; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Disease Progression; Glomerular Filtration Rate; Humans; Hypertension; Kidney Failure, Chronic; Ramipril | 2003 |
Initial findings of the AASK: African Americans with hypertensive kidney disease benefit from an ACE inhibitor.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Black or African American; Female; Humans; Hypertension, Renal; Male; Middle Aged; Ramipril; Randomized Controlled Trials as Topic | 2003 |
[Case report: hypertension after stroke].
Topics: Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Basal Ganglia Cerebrovascular Disease; Blood Pressure Monitoring, Ambulatory; Blood Urea Nitrogen; Body Weight; Cerebral Infarction; Circadian Rhythm; Dose-Response Relationship, Drug; Drug Therapy, Combination; Follow-Up Studies; Glycated Hemoglobin; Humans; Hypertension; Internal Capsule; Male; Oxazoles; Prognosis; Ramipril; Rilmenidine; Sympathetic Nervous System | 2004 |
Liquid chromatographic separation and UV determination of certain antihypertensive agents.
Topics: Amlodipine; Antihypertensive Agents; Chromatography, Thin Layer; Enalapril; Ramipril; Spectrophotometry, Ultraviolet | 2006 |
Differing effects of antihypertensive drugs on the incidence of diabetes mellitus among patients with hypertensive kidney disease.
Topics: Adrenergic beta-Antagonists; Adult; Amlodipine; Antihypertensive Agents; Black or African American; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Hypertension, Renal; Incidence; Male; Metoprolol; Middle Aged; Multicenter Studies as Topic; Ramipril; Randomized Controlled Trials as Topic; Regression Analysis | 2006 |
Antihypertensive agents have different ability to modulate arterial pressure and heart rate variability in 2K1C rats.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Atenolol; Autonomic Nervous System; Blood Pressure; Cardiovascular System; Heart Rate; Hydrochlorothiazide; Hypertension; Losartan; Male; Ramipril; Rats; Rats, Wistar; Sympathetic Nervous System | 2006 |
Angiotensin-converting enzyme inhibition reduces lipid deposits in myocardium and improves left ventricular function of obese zucker rats.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Blood Pressure; Cholesterol; Humans; Insulin; Lipid Metabolism; Male; Ramipril; Random Allocation; Rats; Rats, Zucker; Triglycerides; Ventricular Function, Left | 2006 |
Lack of pharmacokinetic interactions of aliskiren, a novel direct renin inhibitor for the treatment of hypertension, with the antihypertensives amlodipine, valsartan, hydrochlorothiazide (HCTZ) and ramipril in healthy volunteers.
Topics: Adolescent; Adult; Amides; Amlodipine; Antihypertensive Agents; Drug Interactions; Drug Therapy, Combination; Female; Fumarates; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Ramipril; Renin; Renin-Angiotensin System; Tetrazoles; Valine; Valsartan | 2006 |
A stunning day in hypertension research - Results of ONTARGET, ACCOMPLISH and HYVET.
Topics: Amlodipine; Antihypertensive Agents; Benzazepines; Benzimidazoles; Benzoates; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Hypertension; Indapamide; Perindopril; Ramipril; Telmisartan | 2008 |
Effect of the multitargeted receptor tyrosine kinase inhibitor, ABT-869 [N-(4-(3-amino-1H-indazol-4-yl)phenyl)-N'-(2-fluoro-5-methylphenyl)urea], on blood pressure in conscious rats and mice: reversal with antihypertensive agents and effect on tumor growt
Topics: Acrylates; Amlodipine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Dose-Response Relationship, Drug; Enalapril; Humans; Imidazoles; Indazoles; Lisinopril; Male; Mice; Mice, SCID; Neoplasms; Nifedipine; Phenylurea Compounds; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Ramipril; Rats; Rats, Sprague-Dawley; Telmisartan; Thiophenes; Xenograft Model Antitumor Assays | 2009 |
Tako-tsubo cardiomyopathy observed in a patient with sepsis and transient hyperthyroidism.
Topics: Amlodipine; Anti-Bacterial Agents; Antihypertensive Agents; Antithyroid Agents; Aspirin; Echocardiography; Electrocardiography; Female; Glucocorticoids; Humans; Hyperthyroidism; Methimazole; Middle Aged; Ofloxacin; Platelet Aggregation Inhibitors; Prednisone; Propranolol; Ramipril; Sepsis; Takotsubo Cardiomyopathy | 2009 |
Simultaneous determination of atorvastatin, amlodipine, ramipril and benazepril in human plasma by LC-MS/MS and its application to a human pharmacokinetic study.
Topics: Amlodipine; Anticholesteremic Agents; Antihypertensive Agents; Atorvastatin; Benzazepines; Chromatography, Liquid; Drug Stability; Heptanoic Acids; Humans; Least-Squares Analysis; Male; Nevirapine; Pyrroles; Ramipril; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2011 |
Investigation of the effects of the chronic administration of some antihypertensive drugs on enzymatic and non-enzymatic oxidant/antioxidant parameters in rat ovarian tissue.
Topics: Amlodipine; Animals; Antihypertensive Agents; Antioxidants; Clonidine; Female; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Glutathione Transferase; Methyldopa; Ovary; Oxazoles; Oxidants; Ramipril; Rats; Rats, Wistar; Rilmenidine; Superoxide Dismutase | 2011 |
Mixed messages on blood pressure goals.
Topics: Amlodipine; Antihypertensive Agents; Black or African American; Blood Pressure; Glomerular Filtration Rate; Humans; Hypertension; Kidney Diseases; Metoprolol; Ramipril; Treatment Outcome | 2011 |
Thrombin activatable fibrinolysis inhibitor (TAFI) levels in hypertensive patients and a comparison of the effects of amlodipine and ramipril on TAFI levels.
Topics: Adult; Amlodipine; Antihypertensive Agents; Carboxypeptidase B2; Female; Fibrinolysis; Humans; Hypertension; Male; Middle Aged; Ramipril; Statistics, Nonparametric | 2013 |
The safe introduction of angiotensin-converting enzyme inhibitor in renal allograft recipients.
Topics: Adult; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Female; Humans; Kidney Transplantation; Male; Middle Aged; Perindopril; Ramipril; Transplantation, Homologous | 2012 |
[Telangiectasia during amlodipine therapy].
Topics: Amlodipine; Antihypertensive Agents; Bisoprolol; Calcium Channel Blockers; Drug Substitution; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Middle Aged; Ramipril; Telangiectasis | 2013 |
[Medication adherence with the fixed combination of ramipril and amlodipine].
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Databases, Factual; Drug Administration Schedule; Drug Combinations; Drug Prescriptions; Drug Therapy, Combination; Female; Humans; Hungary; Hypertension; Kaplan-Meier Estimate; Male; Medication Adherence; Middle Aged; Proportional Hazards Models; Ramipril | 2014 |
Ramipril/amlodipine single pill - effectiveness, tolerance and patient satisfaction with antihypertensive therapy in relation to nutritional status.
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Drug Combinations; Humans; Hypertension; Medication Adherence; Nutritional Status; Obesity; Overweight; Patient Satisfaction; Ramipril | 2014 |
Single-pill combination therapy in the initial treatment of marked hypertension: a propensity-matched analysis.
Topics: Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Dihydropyridines; Dose-Response Relationship, Drug; Drug Combinations; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Perindopril; Propensity Score; Ramipril; Retrospective Studies; Risk Factors; Telmisartan; Tetrazoles | 2015 |
[Ramipril plus amlodipine and lisinopril plus amlodipine fixed dose combinations and patient's adherence].
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Databases, Factual; Drug Combinations; Female; Humans; Hypertension; Lisinopril; Male; Medication Adherence; Middle Aged; Ramipril; Retrospective Studies | 2016 |
Ramipril + amlodipine and ramipril + hydrochlorothiazide fixed-dose combinations in relation to patient adherence.
Topics: Amlodipine; Antihypertensive Agents; Drug Therapy, Combination; Humans; Hungary; Hydrochlorothiazide; Hypertension; Medication Adherence; Ramipril; Retrospective Studies | 2016 |
Therapy discontinuation or substitution in patients with cardiovascular disease, switching among different products of the same off-patent active substance: a 'real-world' retrospective cohort study.
Topics: Aged; Amlodipine; Antihypertensive Agents; Cardiovascular Diseases; Databases, Factual; Drug Substitution; Drugs, Generic; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Italy; Male; Medication Adherence; Middle Aged; Multivariate Analysis; Ramipril; Retrospective Studies; Simvastatin | 2016 |
[Comparative Assessment of Effects of Free and Fixed Combinations of Hypotensive Drugs on Quality of Life of Patients With Arterial Hypertension of High and Very High Risk].
Topics: Amlodipine; Antihypertensive Agents; Bisoprolol; Blood Pressure; Female; Humans; Hypertension; Indapamide; Lisinopril; Male; Middle Aged; Quality of Life; Ramipril; Random Allocation; Surveys and Questionnaires | 2016 |
[One year adherence of ramipril versus ramipril/amlodipine fixed dose combination therapy in hypertension].
Topics: Amlodipine; Antihypertensive Agents; Drug Combinations; Female; Humans; Hungary; Hypertension; Male; Medication Adherence; Ramipril; Retrospective Studies | 2017 |
Fixed-dose vs free-dose combinations for the management of hypertension-An analysis of 81 958 patients.
Topics: Age Factors; Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Comorbidity; Drug Combinations; Female; Humans; Hypertension; Male; Middle Aged; Patient Compliance; Ramipril; Tetrazoles | 2018 |
Antihypertensive drug use in resistant and nonresistant hypertension and in controlled and uncontrolled resistant hypertension.
Topics: Amlodipine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Bisoprolol; Blood Pressure; Calcium Channel Blockers; Chlorthalidone; Diuretics; Drug Resistance; Drug Therapy, Combination; Humans; Hypertension; Imidazoles; Mineralocorticoid Receptor Antagonists; Ramipril; Tetrazoles | 2018 |
How to Treat Hypertension in Venlafaxine-Medicated Patients-Pharmacokinetic Considerations in Prescribing Amlodipine and Ramipril.
Topics: Amlodipine; Antihypertensive Agents; Cytochrome P-450 CYP2D6 Inhibitors; Databases, Factual; Drug Interactions; Drug Prescriptions; Female; Humans; Hypertension; Male; Ramipril; Serotonin and Noradrenaline Reuptake Inhibitors; Venlafaxine Hydrochloride | 2018 |
Side Effects of Frequently Used Antihypertensive Drugs on Wound Healing in vitro.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Calcium Channel Blockers; Cell Line; Cell Movement; Diuretics; Fibroblasts; Humans; Hydrochlorothiazide; Keratinocytes; Metoprolol; Ramipril; Tetrazoles; Wound Healing | 2019 |
Large underestimation of arterial pressure after vasodilator medication overdose.
Topics: Adolescent; Amlodipine; Arterial Pressure; Critical Care; Drug Overdose; Female; Femoral Artery; Humans; Infusions, Intra-Arterial; Norepinephrine; Radial Artery; Ramipril; Reproducibility of Results; Vasoconstrictor Agents; Vasodilator Agents | 2020 |
Smart UV spectrophotometric methods based on simple mathematical filtration for the simultaneous determination of celecoxib and ramipril in their pharmaceutical mixtures with amlodipine: A comparative statistical study.
Topics: Amlodipine; Celecoxib; Pharmaceutical Preparations; Ramipril; Spectrophotometry | 2021 |
Mechanistic Considerations About an Unexpected Ramipril Drug-Drug Interaction in the Development of a Triple Fixed-Dose Combination Product Containing Ramipril, Amlodipine, and Atorvastatin.
Topics: Adult; Amlodipine; Anticholesteremic Agents; Antihypertensive Agents; Atorvastatin; Biological Availability; Drug Combinations; Drug Interactions; Gastrointestinal Motility; Healthy Volunteers; Humans; Intestinal Absorption; Male; Ramipril; Young Adult | 2021 |
INDICATORS OF ENDOTHELIAL DYSFUNCTION, MARKERS OF INFLAMMATION AND LIPID METABOLISM IN PATIENTS WITH HYPERTENSION WITH THE ADMINISTRATION OF QUERCETIN.
Topics: Adult; Amlodipine; Antihypertensive Agents; Blood Pressure; Female; Humans; Hypertension; Inflammation; Interleukin-1; Lipid Metabolism; Male; Middle Aged; Nitric Oxide; Quercetin; Ramipril | 2022 |
Medicine-Induced Acute Kidney Injury Findings from Spontaneous Reporting Systems, Sequence Symmetry Analysis and a Case-Control Study with a Focus on Medicines Used in Primary Care.
Topics: Acute Kidney Injury; Adverse Drug Reaction Reporting Systems; Amlodipine; Amphotericin B; Australia; Case-Control Studies; Ciprofloxacin; Diclofenac; Furosemide; Humans; Ibuprofen; Metformin; Naproxen; Omeprazole; Primary Health Care; Ramipril; Simvastatin; Spironolactone; Sulfamethoxazole; Telmisartan; Trimethoprim; Valacyclovir; Zoledronic Acid | 2022 |